U.T. MD Anderson Cancer Center, Investigational Pharmacy Services — Houston, Texas

U.T. MD Anderson Cancer Center, Investigational Pharmacy Services is a clinical research site located in Houston, Texas, United States 77030.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

U.T. MD Anderson Cancer Center, Investigational Pharmacy Services has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Metastatic HER2-positive Breast Cancer.

Sponsors: Jazz Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for U.T. MD Anderson Cancer Center, Investigational Pharmacy Services?

U.T. MD Anderson Cancer Center, Investigational Pharmacy Services has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has U.T. MD Anderson Cancer Center, Investigational Pharmacy Services conducted?

U.T. MD Anderson Cancer Center, Investigational Pharmacy Services has 1 clinical trials on record, with 1 currently active. Their work covers Metastatic HER2-positive Breast Cancer.

Is U.T. MD Anderson Cancer Center, Investigational Pharmacy Services accredited by Crixeo Health?

U.T. MD Anderson Cancer Center, Investigational Pharmacy Services has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about U.T. MD Anderson Cancer Center, Investigational Pharmacy Services?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.